38 results on '"Minelli, Silvia"'
Search Results
2. Co-infections observed in SARS-CoV-2 positive patients using a rapid diagnostic test
- Author
-
Fontana, Carla, Favaro, Marco, Minelli, Silvia, Bossa, Maria Cristina, and Altieri, Anna
- Published
- 2021
- Full Text
- View/download PDF
3. Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction
- Author
-
Montone, Rocco A., Niccoli, Giampaolo, Minelli, Silvia, Fracassi, Francesco, Vetrugno, Vincenzo, Aurigemma, Cristina, Burzotta, Francesco, Porto, Italo, Trani, Carlo, and Crea, Filippo
- Published
- 2017
- Full Text
- View/download PDF
4. Closing the Gap in Proteomic Identification of Histoplasma capsulatum : A Case Report and Review of Literature.
- Author
-
Cosio, Terenzio, Gaziano, Roberta, Fontana, Carla, Pistoia, Enrico Salvatore, Petruccelli, Rosalba, Favaro, Marco, Pica, Francesca, Minelli, Silvia, Bossa, Maria Cristina, Altieri, Anna, Ombres, Domenico, Zarabian, Nikkia, and D'Agostini, Cartesio
- Subjects
MATRIX-assisted laser desorption-ionization ,TIME-of-flight mass spectrometry ,LITERATURE reviews ,PROTEOMICS ,SYMPTOMS ,POLYMERASE chain reaction ,HISTOPLASMOSIS - Abstract
Histoplasmosis is a globally distributed systemic infection caused by the dimorphic fungus Histoplasma capsulatum (H. capsulatum). This fungus can cause a wide spectrum of clinical manifestations, and the diagnosis of progressive disseminated histoplasmosis is often a challenge for clinicians. Although microscopy and culture remain the gold standard diagnostic tests for Histoplasma identification, matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) has emerged as a method of microbial identification suitable for the confirmation of dimorphic fungi. However, to our knowledge, there are no entries for H. capsulatum spectra in most commercial databases. In this review, we describe the case of disseminated histoplasmosis in a patient living with HIV admitted to our university hospital that we failed to identify by the MALDI-TOF method due to the limited reference spectrum of the instrument database. Furthermore, we highlight the utility of molecular approaches, such as conventional polymerase chain reaction (PCR) and DNA sequencing, as alternative confirmatory tests to MALDI-TOF technology for identifying H. capsulatum from positive cultures. An overview of current evidence and limitations of MALDI-TOF-based characterization of H. capsulatum is also presented. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time.
- Author
-
Fontana, Carla, Favaro, Marco, Pelliccioni, Marco, Minelli, Silvia, Bossa, Maria Cristina, Altieri, Anna, D'Orazi, Carlo, Paliotta, Federico, Cicchetti, Oriana, Minieri, Marilena, Prezioso, Carla, Limongi, Dolores, and D'agostini, Cartesio
- Subjects
TURNAROUND time ,COVID-19 pandemic ,COVID-19 ,TECHNOLOGICAL innovations ,AUTOMATION - Abstract
Background: Laboratory Automation (LA) is an innovative technology that is currently available for microbiology laboratories. LA can be a game changer by revolutionizing laboratory workflows through efficiency improvement and is also effective in the organization and standardization of procedures, enabling staff requalification. It can provide an important return on investment (time spent redefining the workflow as well as direct costs of instrumentation) in the medium to long term. Methods: Here, we present our experience with the WASPLab
® system introduced in our lab during the COVID-19 pandemic. We evaluated the impact due to the system by comparing the TAT recorded on our samples before, during, and after LA introduction (from 2019 to 2021). We focused our attention on blood cultures (BCs) and biological fluid samples (BLs). Results: TAT recorded over time showed a significant decrease: from 97 h to 53.5 h (Δ43.5 h) for BCs and from 73 h to 58 h (Δ20 h) for BLs. Despite the introduction of the WASPLab® system, we have not been able to reduce the number of technical personnel units dedicated to the microbiology lab, but WASPLab® has allowed us to direct some of the staff resources toward other laboratory activities, including those required by the pandemic. Conclusions: LA can significantly enhance laboratory performance and, due to the significant reduction in reporting time, can have an effective impact on clinical choices and therefore on patient outcomes. Therefore, the initial costs of LA adoption must be considered worthwhile. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Instantaneous Wave-free Ratio versus Fractional Flow Reserve
- Author
-
Montone, Rocco A. and Minelli, Silvia
- Published
- 2017
7. A Complex Case of Angulated and Bifurcated Lesion Facilitated by Excimer Laser Coronary Angioplasty
- Author
-
NICCOLI, GIAMPAOLO, MINELLI, SILVIA, COSENTINO, NICOLA, and CREA, FILIPPO
- Published
- 2011
- Full Text
- View/download PDF
8. New strategies for the management of no-reflow after primary percutaneous coronary intervention
- Author
-
Niccoli, Giampaolo, Cosentino, Nicola, Spaziani, Cristina, Minelli, Silvia, Fracassi, Francesco, and Crea, Filippo
- Published
- 2011
- Full Text
- View/download PDF
9. Antimicrobial resistance in the times of COVID-19 in a roman teaching hospital.
- Author
-
Fontana, Carla, Favaro, Marco, Minelli, Silvia, Cristina Bossa, Maria, Altieri, Anna, Celeste, Mariagrazia, Pennacchiotti, Chiara, Sarmati, Loredana, Andreoni, Massimo, Cucchi, Carmela, and Magrini, Andrea
- Subjects
DRUG resistance in microorganisms ,COVID-19 pandemic ,COVID-19 ,SARS-CoV-2 ,HOSPITAL admission & discharge ,STAPHYLOCOCCUS - Abstract
Objective:Atroublesome implication of the COVID-19 pandemic has been an increased incidence of antimicrobial resistance. Implementation of containment measures, surveillance and monitoring of multiresistant microorganisms and/or alert organisms (MDROs_AL) should be strengthened. Here, we present the results of our observational study in which the isolation trend of MDROs_AL was compared over several quarters before and during the SARS-CoV-2 pandemic (2019-2020). Results: Although in our hospital the number of hospital admissions decreased significantly during the SARS-CoV-2 pandemic (due to the conversion of our hospital to a COVID hospital), the incidence rate of MDRO_AL infection increased from 18.0-34.6. (incidence rate) Among the MDROs_AL, A. baumannii, carbapenem-resistant enterobacteria, staphylococci/streptococci-MLSB, intermediate/glycopeptide-resistant coagulase-negative staphylococci and vancomycin-resistant enterococci were the most represented. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Emergence of KPC-producing Klebsiella pneumoniae in Italy
- Author
-
Bossa Maria C, Altieri Anna, Natoli Silvia, Sarmati Loredana, Favaro Marco, Fontana Carla, Minelli Silvia, Leonardis Francesca, and Favalli Cartesio
- Subjects
Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics. Therefore, infection control guidelines on early identification and control of the spread of organisms carrying these resistant determinants are needed. Findings Klebsiella pneumoniae carbapenemase (KPC) was detected in two isolates of carbapenem-resistant K. pneumoniae obtained from patients at an Italian teaching hospital. The first strain was isolated from a culture drawn from a central venous device (CVC) in a patient with Crohn's disease who was admitted to a gastroenterology ward. The second was isolated from a urine sample collected from an indwelling urinary catheter in an intensive care unit (ICU) patient with a subdural haematoma. The patients had not travelled abroad. Both isolates were resistant to all β-lactams and were susceptible to imipenem and meropenem but resistant to ertapenem. Isolates also showed resistance to other classes of non-β-lactam antibiotics, such as quinolones, aminoglycosides (with the exception for amikacin), trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin. They were determined to contain the plasmid encoding the carbapenemase gene bla-KPC and were also positive in the Hodge test. Conclusions This is the second report of KPC-producing isolates in Italy, but the first concerning KPC type 2 gene, and it may have important implications for controlling the transmission of microorganisms resistant to antibiotics.
- Published
- 2010
- Full Text
- View/download PDF
11. Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options
- Author
-
Natoli Silvia, Fontana Carla, Favaro Marco, Bergamini Alberto, Testore Gian, Minelli Silvia, Bossa Maria, Casapulla Mauro, Broglio Giorgia, Beltrame Angela, Cudillo Laura, Cerretti Raffaella, and Leonardis Francesca
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Coagulase-negative staphylococci (CoNS) are a major cause of nosocomial blood stream infection, especially in critically ill and haematology patients. CoNS are usually multidrug-resistant and glycopeptide antibiotics have been to date considered the drugs of choice for treatment. The aim of this study was to characterize CoNS with reduced susceptibility to glycopeptides causing blood stream infection (BSI) in critically ill and haematology patients at the University Hospital Tor Vergata, Rome, Italy, in 2007. Methods Hospital microbiology records for transplant haematology and ICU were reviewed to identify CoNS with elevated MICs for glycopeptides, and isolates were matched to clinical records to determine whether the isolates caused a BSI. The isolates were tested for susceptibility to new drugs daptomicin and tigecycline and the genetic relationship was assessed using f-AFLP. Results Of a total of 17,418 blood cultures, 1,609 were positive for CoNS and of these, 87 (5.4%) displayed reduced susceptibility to glycopeptides. Clinical review revealed that in 13 cases (7 in haematology and 6 in ICU), CoNS with reduced susceptibility to glycopeptides were responsible for a BSI. Staphylococcus epidermidis was the causative organism in 11 instances and Staphylococcus haemolyticus in 2. The incidence of oxacillin resistance was high (77%), although all isolates remained susceptible to linezolid, daptomycin and tigecycline. Fingerprinting of CoNS identified one clonal relationship between two isolates. Conclusion Multi-resistant CoNS with reduced susceptibility to glycopeptides, although still relatively infrequent in our hospital, are emerging pathogens of clinical concern. Surveillance by antibiotyping with attention to multi-resistant profile, and warning to clinicians, is necessary.
- Published
- 2009
- Full Text
- View/download PDF
12. Acinetobacter baumannii in intensive care unit: A novel system to study clonal relationship among the isolates
- Author
-
Leonardis Francesca, Testore Gian, Bossa Maria, Minelli Silvia, Favaro Marco, Fontana Carla, Natoli Silvia, and Favalli Cartesio
- Subjects
Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background The nosocomial infections surveillance system must be strongly effective especially in highly critic areas, such as Intensive Care Units (ICU). These areas are frequently an epidemiological epicentre for transmission of multi-resistant pathogens, like Acinetobacter baumannii. As an epidemic outbreak occurs it is very important to confirm or exclude the genetic relationship among the isolates in a short time. There are several molecular typing systems used with this aim. The Repetitive sequence-based PCR (REP-PCR) has been recognized as an effective method and it was recently adapted to an automated format known as the DiversiLab system. Methods In the present study we have evaluated the combination of a newly introduced software package for the control of hospital infection (VIGI@ct) with the DiversiLab system. In order to evaluate the reliability of the DiversiLab its results were also compared with those obtained using f-AFLP. Results The combination of VIGI@ct and DiversiLab enabled an earlier identification of an A. baumannii epidemic cluster, through the confirmation of the genetic relationship among the isolates. This cluster regards 56 multi-drug-resistant A. baumannii isolates from several specimens collected from 13 different patients admitted to the ICU in a ten month period. The A. baumannii isolates were clonally related being their similarity included between 97 and 100%. The results of the DiversiLab were confirmed by f-AFLP analysis. Conclusion The early identification of the outbreak has led to the prompt application of operative procedures and precautions to avoid the spread of pathogen. To date, 6 months after the last A. baumannii isolate, no other related case has been identified.
- Published
- 2008
- Full Text
- View/download PDF
13. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.
- Author
-
Montone, Rocco A., Niccoli, Giampaolo, Tufaro, Vincenzo, Minelli, Silvia, Russo, Michele, Vergni, Federico, Sommariva, Luigi, Pelliccia, Francesco, Bedogni, Francesco, and Crea, Filippo
- Subjects
PERCUTANEOUS coronary intervention ,ATRIAL fibrillation ,INTERNATIONAL normalized ratio ,KIDNEY diseases ,GLOMERULAR filtration rate ,CONTRAST induced nephropathy - Abstract
Introduction: Patients with atrial fibrillation (AF) receiving non-vitamin K oral anticoagulants (NOAC) have a slower decline in renal function than those taking warfarin. Moreover, a warfarin-related nephropathy has been described. Aim: We assessed variation of estimated glomerular filtration rate (eGFR) and occurrence of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients with AF taking warfarin compared with NOAC. Material and methods: We retrospectively enrolled consecutive patients taking oral anticoagulation for AF undergoing PCI. The primary endpoint was variation in eGFR and serum creatinine levels within 48-72 h after PCI. The secondary endpoint was occurrence of CIN, defined as a ≥ 25% relative increase, or a ≥ 0.5 mg/dl absolute increase, in serum creatinine levels within 48-72 h. Results: We enrolled 420 patients (mean age: 75.0 ±5.5 years, 272 (64.7%) male), 124 (29.5%) treated with NOAC and 296 (70.5%) with warfarin. NOAC patients showed a reduced decline in renal function (eGFR change: -2.8 ±7.9 ml/min/1.73 m2 vs. -4.5 ±6.5 ml/min/1.73 m2, respectively, p = 0.02) and a smaller increase in serum creatinine levels (0.026 ±0.112 vs. 0.055 ±0.132, p = 0.032) after PCI compared with warfarin. In the multivariate linear regression model independent predictors of eGFR changes were diabetes, baseline eGFR ≤ 60 ml/min/1.73 m2 and warfarin use. Occurrence of CIN did not differ between NOAC and warfarin patients (13 (10.5%) vs. 46 (15.5%), p = 0.22). Conclusions: Patients with AF taking NOAC have a reduced decline in renal function after PCI compared with warfarin. The NOAC may be a reasonable option for patients with a high risk of developing CIN. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
14. An in-depth analysis of nosocomial bloodstream infections due to Gram-negative bacilli: clinical features, microbiological characteristics and predictors of mortality in a 1 year, prospective study in a large tertiary care Italian hospital.
- Author
-
Delle Rose, Diego, Pezzotti, Patrizio, Fontana, Carla, Altieri, Anna, Minelli, Silvia, Mariotti, Benedetta, Cerretti, Raffaella, Leoni, Davide, Andreoni, Massimo, and Sarmati, Loredana
- Abstract
Background: Bloodstream infections (BSI) due to Gram negative bacilli (GNB) represent a major concern among nosocomial infections, since they are noticeably associated with a high mortality rates, increase of healthcare costs and prolongation of hospital stay. Methods: Over a 12-month period (2014-2015) all the adult patients admitted to a university-based Italian hospital were monitored for development of BSIs due to GNB. Multiple logistics regression models were performed to assess the impact of patients' risk factors on the in-hospital and 14-day mortality. Results: During the study period 208 patients were diagnosed with at least a BSI due to a Gram negative species for an incidence rate of 12.8 cases/1,000 admissions (95%CI: 11.2-14.7). Multivariate analyses showed that multiple organ dysfunctions along with immune deficit and inadequate therapy in the first 48hrs were associated with a higher risk of death. Conclusions: A thorough evaluation of both immune status and organ dysfunction at the onset of septic events, along with adequate antimicrobial therapy appear to be the most reliable factors in predicting the outcome in these infections. SOFA score can be efficaciously substituted to the single organ dysfunctions analysis in predicting mortality after these events. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
15. Very late stent thrombosis complicating a previously lost and partially crushed stent: Demonstration by optical coherence tomography
- Author
-
Montone, Rocco A., Cataneo, Leonardo, Minelli, Silvia, and Niccoli, Giampaolo
- Published
- 2012
- Full Text
- View/download PDF
16. A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: Effect of length of follow-up on clinical outcome
- Author
-
Niccoli, Giampaolo, Leo, Andrea, Giubilato, Simona, Cosentino, Nicola, Galassi, Alfredo Ruggero, Minelli, Silvia, Porto, Italo, Leone, Antonio Maria, Burzotta, Francesco, Trani, Carlo, and Crea, Filippo
- Published
- 2011
- Full Text
- View/download PDF
17. Microvascular obstruction is an independent predictor of major adverse cardiovascular events in latecomers after ST-elevation myocardial infarction
- Author
-
Montone, Rocco A., Niccoli, Giampaolo, Minelli, Silvia, and Crea, Filippo
- Published
- 2017
- Full Text
- View/download PDF
18. Temporal Trends in Adverse Events After Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: A Meta-Analysis of Randomized Controlled Trials.
- Author
-
Montone, Rocco A., Niccoli, Giampaolo, De Marco, Federico, Minelli, Silvia, D'Ascenzo, Fabrizio, Testa, Luca, Bedogni, Francesco, and Crea, Filippo
- Published
- 2017
- Full Text
- View/download PDF
19. Coronary In-Stent Restenosis in Patients Treated With Thoracic External Beam Radiation for Cancer
- Author
-
Montone, Rocco A., Minelli, Silvia, and Niccoli, Giampaolo
- Published
- 2015
- Full Text
- View/download PDF
20. Emergence of KPC-producing Klebsiellapneumoniae in Italy.
- Author
-
Fontana, Carla, Favaro, Marco, Sarmati, Loredana, Natoli, Silvia, Altieri, Anna, Bossa, Maria C., Minelli, Silvia, Leonardis, Francesca, and Favalli, Cartesio
- Subjects
KLEBSIELLA pneumoniae ,ANTIBIOTICS ,KLEBSIELLA ,GASTROENTEROLOGY ,HEMATOMA ,INTENSIVE care units ,AMINOGLYCOSIDES ,DRUG resistance in microorganisms - Abstract
Background: The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC betalactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics. Therefore, infection control guidelines on early identification and control of the spread of organisms carrying these resistant determinants are needed. Findings: Klebsiella pneumoniae carbapenemase (KPC) was detected in two isolates of carbapenem-resistant K. pneumoniae obtained from patients at an Italian teaching hospital. The first strain was isolated from a culture drawn from a central venous device (CVC) in a patient with Crohn's disease who was admitted to a gastroenterology ward. The second was isolated from a urine sample collected from an indwelling urinary catheter in an intensive care unit (ICU) patient with a subdural haematoma. The patients had not travelled abroad. Both isolates were resistant to all β-lactams and were susceptible to imipenem and meropenem but resistant to ertapenem. Isolates also showed resistance to other classes of non-β-lactam antibiotics, such as quinolones, aminoglycosides (with the exception for amikacin), trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin. They were determined to contain the plasmid encoding the carbapenemase gene bla-KPC and were also positive in the Hodge test. Conclusions: This is the second report of KPC-producing isolates in Italy, but the first concerning KPC type 2 gene, and it may have important implications for controlling the transmission of microorganisms resistant to antibiotics. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
21. Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae subsp. pneumoniae Isolates in a Tertiary Italian Hospital: Identification of a New Mutation of the Carbapenemase Type 3 (KPC-3) Gene Conferring Ceftazidime/Avibactam Resistance.
- Author
-
Fontana, Carla, Favaro, Marco, Campogiani, Laura, Malagnino, Vincenzo, Minelli, Silvia, Bossa, Maria Cristina, Altieri, Anna, Andreoni, Massimo, and Sarmati, Loredana
- Subjects
KLEBSIELLA pneumoniae ,CARBAPENEMASE ,GENETIC mutation ,HOSPITALS ,CEFTAZIDIME ,THYMINE ,ADENINE - Abstract
Several Klebsiella pneumoniae carpabenemase (KPC) gene mutations are associated with ceftazidime/avibactam (CAZ-AVI) resistance. Here, we describe four Klebsiella pneumoniae subsp. pneumoniae CAZ-AVI-resistant clinical isolates, collected at the University Hospital of Tor Vergata, Rome, Italy, from July 2019 to February 2020. These resistant strains were characterized as KPC-3, having the transition from cytosine to thymine (CAC-TAC) at nucleotide position 814, with histidine that replaces tyrosine (H272Y). In addition, two different types of KPC gene mutations were detected. The first one, common to three strains, was the D179Y (G532T), associated with CAZ-AVI resistance. The second mutation, found only in one strain, is a new mutation of the KPC-3 gene: a transversion from thymine to adenine (CTG-CAG) at nucleotide position 553. This mutation causes a KPC variant in which glutamine replaces leucine (Q168L). None of the isolates were detected by a rapid immunochromatographic assay for detection of carbapenemase (NG Biotech, Guipry, France) and were unable to grow on a selective chromogenic medium Carba SMART (bioMerieux, Firenze, Italy). Thus, they escaped common tests used for the prompt detection of Klebsiella pneumoniae KPC-producing. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Acinetobacter baumannii in intensive care unit: A novel system to study clonal relationship among the isolates.
- Author
-
Fontana, Carla, Favaro, Marco, Minelli, Silvia, Bossa, Maria Cristina, Testore, Gian Piero, Leonardis, Francesca, Natoli, Silvia, and Favalli, Cartesio
- Subjects
ACINETOBACTER infections ,INTENSIVE care units ,NOSOCOMIAL infections ,POLYMERASE chain reaction ,COMPUTER software ,MULTIDRUG resistance - Abstract
Background: The nosocomial infections surveillance system must be strongly effective especially in highly critic areas, such as Intensive Care Units (ICU). These areas are frequently an epidemiological epicentre for transmission of multi-resistant pathogens, like Acinetobacter baumannii. As an epidemic outbreak occurs it is very important to confirm or exclude the genetic relationship among the isolates in a short time. There are several molecular typing systems used with this aim. The Repetitive sequence-based PCR (REP-PCR) has been recognized as an effective method and it was recently adapted to an automated format known as the DiversiLab system. Methods: In the present study we have evaluated the combination of a newly introduced software package for the control of hospital infection (VIGI@ct) with the DiversiLab system. In order to evaluate the reliability of the DiversiLab its results were also compared with those obtained using f-AFLP. Results: The combination of VIGI@ct and DiversiLab enabled an earlier identification of an A. baumannii epidemic cluster, through the confirmation of the genetic relationship among the isolates. This cluster regards 56 multi-drug-resistant A. baumannii isolates from several specimens collected from 13 different patients admitted to the ICU in a ten month period. The A. baumannii isolates were clonally related being their similarity included between 97 and 100%. The results of the DiversiLab were confirmed by f-AFLP analysis. Conclusion: The early identification of the outbreak has led to the prompt application of operative procedures and precautions to avoid the spread of pathogen. To date, 6 months after the last A. baumannii isolate, no other related case has been identified. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
23. SERUM LEVELS OF GAMMA-GLUTAMYL TRANSFERASE PREDICT CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH ISCHEMIC HEART DISEASE UNDER OPTIMAL MEDICAL THERAPY
- Author
-
Biasucci, Luigi M., Bona, Roberta Della, Cosentino, Nicola, Niccoli, Gianpaolo, Minelli, Silvia, Gustapane, Massimo, Cialdella, Pio, Bellone, Flavia, Basile, Eloisa, Biasillo, Gina, and Crea, Filippo
- Published
- 2011
- Full Text
- View/download PDF
24. Excimer laser coronary angioplasty with manual thrombus aspiration for a case of very late stent thrombosis of sirolimus-eluting stent.
- Author
-
Niccoli, Giampaolo, Minelli, Silvia, Cosentino, Nicola, and Crea, Filippo
- Published
- 2012
- Full Text
- View/download PDF
25. Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.
- Author
-
Niccoli, Giampaolo, Calvieri, Camilla, Minelli, Silvia, Copponi, Giorgia, Montone, Rocco, Imaeva, Asiya, Roberto, Marco, Cosentino, Nicola, and Crea, Filippo
- Subjects
- *
DRUG-eluting stents , *EOSINOPHILS , *BASIC proteins , *C-reactive protein , *BIOMARKERS , *SYMPTOMS - Abstract
Aim : To assess eosinophil cationic protein (ECP) and C-reactive protein (CRP) serum levels at three time points according to different stent types. Methods : 54 patients (age 64 ± 10 years, male 78%), undergoing Bare Metal Stent (BMS) ( n = 11), mammalian Target Of Rapamycin (mTOR)-inhibitor DES ( n = 27) and mTOR-inhibitor bioabsorbable DES (BES) ( n = 16) implantation for stable angina (SA) or non-ST-elevation acute coronary syndromes (NSTE-ACS), were prospectively enrolled. ECP and CRP serum levels were assessed before revascularization, at 1-month and at 1-year after the procedure. Moreover, 21 patients found to have inducible ischemia or angina symptoms at 6 month-stress test underwent 1-year follow-up (FU) angiography. Results : Baseline and 1-month ECP levels were similar among the 3 groups, whilst 1-year ECP was significantly higher in m-TOR-DES [8.61 (6.55–19.77) μg/ml] compared with m-TOR-BES [2.03 (1.78–5.53) μg/ml] and BMS-treated patients [2.23 (1.45–8.95) μg/ml] ( p = 0.02), without significant difference between BES and BMS. CRP was similar among the 3 groups at all time points. 1-year ECP significantly correlated with late loss in patients undergoing FU angiography ( r = 0.64, p = 0.002), while CRP did not ( p = NS). Conclusions : Our finding suggests that mTOR-DES stent type is associated with an increase of ECP levels at 1-year, possibly reflecting a persistent eosinophil activation triggered by permanent polymer. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
26. Rapid and cost-effective identification and antimicrobial susceptibility testing in patients with Gram-negative bacteremia directly from blood-culture fluid.
- Author
-
Sakarikou, Christina, Altieri, Anna, Bossa, Maria Cristina, Minelli, Silvia, Dolfa, Camilla, Piperno, Micol, and Favalli, Cartesio
- Subjects
- *
BACTEREMIA diagnosis , *GRAM-negative bacterial diseases , *ANTI-infective agents , *DISEASE susceptibility , *CELL culture , *COST effectiveness , *DIAGNOSIS - Abstract
Rapid pathogen identification (ID) and antimicrobial susceptibility testing (AST) in bacteremia cases or sepsis could improve patient prognosis. Thus, it is important to provide timely reports, which make it possible for clinicians to set up appropriate antibiotic therapy during the early stages of bloodstream infection (BSI). This study evaluates an in-house microbiological protocol for early ID as well as AST on Gram negative bacteria directly from positive monomicrobial and polymicrobial blood cultures (BCs). A total of 102 non-duplicated positive BCs from patients with Gram-negative bacteremia were tested. Both IDs and ASTs were performed from bacterial pellets extracted directly from BCs using our protocol, which was applied through the combined use of a MALDI-TOF MS and Vitek2 automated system. The results of our study showed a 100% agreement in bacterial ID and 98.25% categorical agreement in AST when compared to those obtained by routine conventional methods. We recorded only a 0.76% minor error (mE), 0.76% major error (ME) and a 0.20% very major error (VME). Moreover, the turnaround time (TAT) regarding the final AST report was significantly shortened (ΔTAT = 8–20 h, p < 0.00001). This in-house protocol is rapid, easy to perform and cost effective and could be successfully introduced into any clinical microbiology laboratory. A final same-day report of ID and AST improves patient management, by early and appropriate antimicrobial treatment and could potentially optimize antimicrobial stewardship programs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. Corrigendum to “Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein” [Atherosclerosis 237 (2014) 816–820].
- Author
-
Niccoli, Giampaolo, Calvieri, Camilla, Minelli, Silvia, Copponi, Giorgia, Montone, Rocco A., Imaeva, Asiya, Roberto, Marco, Cosentino, Nicola, and Crea, Filippo
- Subjects
- *
PUBLISHED errata , *EOSINOPHILS , *DRUG-eluting stents , *MEDICAL polymers , *C-reactive protein , *CORONARY disease , *BASIC proteins , *DRUG efficacy - Published
- 2015
- Full Text
- View/download PDF
28. Eosinophil cationic protein and clinical outcome after bare metal stent implantation
- Author
-
Niccoli, Giampaolo, Sgueglia, Gregory A., Conte, Micaela, Cosentino, Nicola, Minelli, Silvia, Belloni, Flavia, Trani, Carlo, Sabato, Vito, Burzotta, Francesco, Porto, Italo, Leone, Antonio Maria, Schiavino, Domenico, and Crea, Filippo
- Subjects
- *
BASIC proteins , *EOSINOPHILIA , *SURGICAL stents , *BIOMARKERS , *HEALTH outcome assessment , *FOLLOW-up studies (Medicine) , *INFLAMMATION - Abstract
Abstract: Objective: we assessed the association between baseline eosinophil cationic protein (ECP) levels, a sensitive marker of eosinophil activation, and clinical outcome in patients undergoing bare metal stent (BMS) implantation. Methods: basal ECP levels were measured in 110 patients (69±11 years, 88 men) undergoing BMS implantation. Major adverse cardiac events (MACEs), defined as cardiac death, non-fatal myocardial infarction, or clinically-driven target lesion revascularization, were registered at 24-month follow-up. Results: eighteen (16.4%) patients had MACEs and showed higher ECP levels compared with those without MACEs [20.1 (9.8–47.3) vs. 9.5 (5.0–27.2)g/L, p =0.02]. At follow-up, ECP level >11g/L was the only significant predictor of MACEs (HR 3.5, 95% CI 1.1–10.4, p =0.03). Conclusion: basal ECP levels are associated with MACEs after BMS implantation, suggesting that an allergic-mediated inflammation against the metal could explain some adverse reactions occurring after coronary stenting. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
29. Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin.
- Author
-
Montone RA, Niccoli G, Tufaro V, Minelli S, Russo M, Vergni F, Sommariva L, Pelliccia F, Bedogni F, and Crea F
- Abstract
Introduction: Patients with atrial fibrillation (AF) receiving non-vitamin K oral anticoagulants (NOAC) have a slower decline in renal function than those taking warfarin. Moreover, a warfarin-related nephropathy has been described., Aim: We assessed variation of estimated glomerular filtration rate (eGFR) and occurrence of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients with AF taking warfarin compared with NOAC., Material and Methods: We retrospectively enrolled consecutive patients taking oral anticoagulation for AF undergoing PCI. The primary endpoint was variation in eGFR and serum creatinine levels within 48-72 h after PCI. The secondary endpoint was occurrence of CIN, defined as a ≥ 25% relative increase, or a ≥ 0.5 mg/dl absolute increase, in serum creatinine levels within 48-72 h., Results: We enrolled 420 patients (mean age: 75.0 ±5.5 years, 272 (64.7%) male), 124 (29.5%) treated with NOAC and 296 (70.5%) with warfarin. NOAC patients showed a reduced decline in renal function (eGFR change: -2.8 ±7.9 ml/min/1.73 m
2 vs. -4.5 ±6.5 ml/min/1.73 m2 , respectively, p = 0.02) and a smaller increase in serum creatinine levels (0.026 ±0.112 vs. 0.055 ±0.132, p = 0.032) after PCI compared with warfarin. In the multivariate linear regression model independent predictors of eGFR changes were diabetes, baseline eGFR ≤ 60 ml/min/1.73 m2 and warfarin use. Occurrence of CIN did not differ between NOAC and warfarin patients (13 (10.5%) vs. 46 (15.5%), p = 0.22)., Conclusions: Patients with AF taking NOAC have a reduced decline in renal function after PCI compared with warfarin. The NOAC may be a reasonable option for patients with a high risk of developing CIN., Competing Interests: The authors declare no conflict of interest.- Published
- 2019
- Full Text
- View/download PDF
30. Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic significance.
- Author
-
Niccoli G, Cosentino N, Minelli S, Cataneo L, and Crea F
- Subjects
- Animals, Arterial Occlusive Diseases diagnosis, Arterial Occlusive Diseases physiopathology, Humans, Myocardial Infarction diagnosis, Myocardial Reperfusion Injury physiopathology, Postoperative Complications physiopathology, Prognosis, Arterial Occlusive Diseases etiology, Microcirculation physiology, Myocardial Infarction etiology, Myocardial Infarction surgery, Myocardial Reperfusion Injury diagnosis, Myocardial Reperfusion Injury etiology, Percutaneous Coronary Intervention adverse effects, Postoperative Complications diagnosis, Postoperative Complications etiology
- Abstract
The primary goal in reopening an infarct-related artery is the restoration of myocardial tissue-level perfusion. In a variable proportion of patients with ST-elevation myocardial infarction, however, microcirculatory impairment may persist after epicardial coronary artery recanalization. This phenomenon is known as microvascular obstruction (MVO). Ischemic injury, reperfusion injury, and distal embolization along with the individual response to each of these mechanisms are variably involved in the pathogenesis of MVO in the single patient. Importantly, MVO is associated with a worse prognosis both at short- and long-term follow-up. MVO can be assessed in the cath-lab by simple angiographic indexes, such as Thrombolysis in Myocardial Infarction grade score and Myocardial Blush Grade, or by invasive measures of coronary flow pattern. Imaging techniques, such as myocardial contrast echocardiography or cardiac magnetic resonance, and ST-segment resolution on standard electrocardiogram are used in the days following reperfusion with the patient in the coronary care unit. In this article, we review the available data regarding pathogenesis, diagnosis and the prognostic significance of MVO after primary percurtaneous coronary intervention in ST-elevation myocardial infarction patients, with a brief highlighting on the crucial role of its prevention and its early detection.
- Published
- 2013
31. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
- Author
-
Niccoli G, Cosentino N, Lombardo A, Sgueglia GA, Spaziani C, Fracassi F, Cataneo L, Minelli S, Burzotta F, Maria Leone A, Porto I, Trani C, and Crea F
- Subjects
- Aged, Chi-Square Distribution, Echocardiography, Female, Humans, Italy, Logistic Models, Male, Middle Aged, Myocardial Infarction diagnostic imaging, Myocardial Infarction physiopathology, No-Reflow Phenomenon etiology, Odds Ratio, Time Factors, Treatment Outcome, Angioplasty, Balloon, Coronary adverse effects, Coronary Angiography, Coronary Circulation, Myocardial Infarction therapy, Myocardial Perfusion Imaging methods, No-Reflow Phenomenon diagnostic imaging, No-Reflow Phenomenon physiopathology, Ventricular Function, Left, Ventricular Remodeling
- Abstract
Background: No reflow after primary percutaneous coronary intervention is a dynamic process and its reversibility may affect left ventricular (LV) remodeling. We aimed at assessing in-hospital evolution of angiographic no reflow, predictors of its reversibility, and its impact on LV function at follow-up (FU)., Methods: Fifty-three consecutive patients (age, 60±10 years; male sex, 79%) presenting with ST-elevation myocardial infarction and undergoing primary percutaneous coronary intervention within 12 h of symptom onset were enrolled. No reflow was defined as a final thrombolysis in myocardial infarction (TIMI) flow of 2 or final TIMI flow of 3 with myocardial blush grade (MBG) of less than 2. The evolution of angiographic no reflow was assessed by repeat in-hospital coronary angiography. Patients with no reflow found to have an improvement of TIMI and/or MBG leading to a final TIMI 3 and MBG of greater than or equal to 2 were classified as reversible no reflow; the remaining patients were classified as sustained no reflow. Variables predicting the patterns of no reflow, recorded on admission, were assessed among clinical, angiographic and laboratory data. FU echocardiographic data (at 6 months) were compared with those obtained in-hospital according to no reflow evolution., Results: Thirty-six patients (68%) exhibited myocardial reperfusion; 17 patients (32%) showed no reflow. Among these, six patients (age, 58±10 years; male sex, 83%) showed sustained no reflow, whereas 11 patients (age, 55±8 years; male sex, 82%) showed reversible no reflow. Patients with sustained no reflow had longer time to percutaneous coronary intervention (261±80 min) compared with those with myocardial reperfusion (216±94 min) or reversible no reflow (237±76 min; P=0.008 and 0.05, respectively). Moreover, patients with sustained no reflow had a higher peak troponin-T levels (14.5 ng/ml; range, 7.5-20.2 ng/ml) compared with those presenting with myocardial reperfusion (3.9 ng/ml; range, 3.3-9.1 ng/ml) and reversible no reflow (7.7 ng/ml; range, 3.6-29.9 ng/ml; P=0.03 and 0.07, respectively). At multivariate ordinal logistic regression, time pre-PCI retained its statistical significant association with angiographic no reflow evolution (odds ratio=2.54; 95% confidence interval: 1.45-6.53; P=0.04), with troponin T levels showing a borderline statistical significance (odds ratio=3.12; 95% confidence interval: 1.07-6.23; P=0.09). Finally, in patients with sustained no reflow only both end-diastolic and end-systolic volumes significantly increased at FU (P<0.001 and 0.001, respectively)., Conclusion: Sustained no reflow is associated with a longer ischemic time and predicts worse LV remodeling. No reflow, however, shows an in-hospital reversibility calling for therapeutic interventions when its prevention fails.
- Published
- 2011
- Full Text
- View/download PDF
32. [Clinical value of inflammatory biomarkers after stent implantation].
- Author
-
Niccoli G, Montone RA, Ferrante G, Minelli S, and Crea F
- Subjects
- Angioplasty, Balloon, Coronary methods, Biomarkers blood, Coronary Artery Disease therapy, Coronary Restenosis etiology, Drug Therapy, Combination, Drug-Eluting Stents adverse effects, Evidence-Based Medicine, Glucocorticoids therapeutic use, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Inflammation blood, Inflammation prevention & control, Platelet Aggregation Inhibitors therapeutic use, Predictive Value of Tests, Prognosis, Risk Assessment, Sensitivity and Specificity, Thrombosis blood, Thrombosis prevention & control, Treatment Outcome, C-Reactive Protein metabolism, Coronary Restenosis blood, Coronary Restenosis prevention & control, Stents adverse effects
- Abstract
The introduction of coronary stents into clinical practice has revolutionized the treatment of coronary artery disease. However, in-stent restenosis (ISR) and stent thrombosis represent the main adverse reactions following stent implantation. Along with procedural and technical factors, individual susceptibility, in particular the inflammatory response, play an important role in the development of these complications. C-reactive protein, one of the most extensively studied inflammatory biomarkers, was found to predict the risk of ISR but not of stent thrombosis in bare-metal stent (BMS)-treated patients. On the contrary, C-reactive protein failed to predict the occurrence of ISR in drug-eluting stent (DES)-treated patients, but it appeared to predict the risk of stent thrombosis. Important differences in the pathophysiological mechanisms of adverse reactions to BMS and DES account for the differences in the prognostic value of inflammatory biomarkers. Moreover, DES polymers are responsible for late hypersensitivity allergic reactions that may lead to late ISR and stent thrombosis. Notably, a correct employment of inflammatory biomarkers may become a useful tool for identification and management of high-risk patients. In this review, the evolving role of inflammatory biomarkers in predicting adverse reactions after stent implantation is discussed, underlying therapeutic and clinical consequences for the management of patients receiving a BMS or a DES.
- Published
- 2011
- Full Text
- View/download PDF
33. [Myocardial no-reflow phenomenon: recent knowledges].
- Author
-
Pontecorvo ML, Spaziani C, Montone RA, Cosentino N, Minelli S, and Niccoli G
- Subjects
- Angioplasty, Balloon, Coronary, Humans, Myocardial Infarction therapy, No-Reflow Phenomenon diagnosis, No-Reflow Phenomenon etiology, No-Reflow Phenomenon therapy
- Abstract
Early revascularization of the infarct-related artery by primary percutaneous coronary intervention (PPCI) has become the gold standard therapy in ST-segment elevation myocardial infarction (STEMI). However, in a number of patient undergoing PPCI, epicardial coronary artery reperfusion: does not translate into myocardial reperfusion: a phenomenon called as no-reflow. The no-reflow phenomenon has a multifactorial pathogenesis, including: distal embolization, ischemia-reperfusion injury, and individual predisposition of coronary microcirculation to injury. Angiographic and electrocardiographic indexes may be used for the diagnosis. Also, lack of ST-segment elevation resolution is considered an established marker of no-reflow. Importantly, the no-reflow phenomenon provides prognostic information in STEMI patients because it is associated with low ventricular ejection fraction, adverse left ventricular remodelling and mortality at follow-up. Various mechanical devices and pharmacological approaches have been proposed to prevent and to treat the phenomenon: the assessment of mechanisms of no-reflow might guide the development of personalized form of treatment. This paper will be focused on the postulated mechanisms of the phenomenon, modalities for the diagnosis, and the main treatment options.
- Published
- 2011
34. Baseline C-reactive protein serum levels and in-stent restenosis pattern after m-TOR inhibitors drug-eluting stent implantation.
- Author
-
Niccoli G, Conte M, Cosentino N, Todaro D, Brugaletta S, Montone RA, Minelli S, Fracassi F, Galiffa V, Leone AM, Burzotta F, Porto I, Trani C, and Crea F
- Subjects
- Aged, Coronary Angiography, Coronary Restenosis classification, Coronary Restenosis diagnostic imaging, Diabetic Angiopathies blood, Diabetic Angiopathies pathology, Diabetic Angiopathies therapy, Female, Humans, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction blood, Myocardial Infarction pathology, Myocardial Infarction therapy, Prognosis, Prosthesis Implantation, Retrospective Studies, TOR Serine-Threonine Kinases antagonists & inhibitors, C-Reactive Protein analysis, Coronary Restenosis blood, Coronary Restenosis pathology, Drug-Eluting Stents
- Abstract
Background: A diffuse pattern of in-stent restenosis (ISR) has been shown to have a worse prognosis when compared to a focal pattern. It is still unknown whether baseline C-reactive protein (CRP) levels predict ISR pattern., Methods: Our database was searched retrospectively for patients presenting with ISR after m-TOR inhibitor drug-eluting stent (DES) implantation from January 2007 to December 2009. Angiographic restenosis patterns were evaluated according to the simplified Mehran classification and patients were allocated either to the diffuse or focal pattern group. Predictors of restenosis pattern were assessed among clinical, angiographic, procedural and laboratory data, including baseline high-sensitivity CRP, recorded at the time of the first percutaneous intervention., Results: 72 patients (age, 65 ± 9 years; male sex, 64%) found to have ISR after DES implantation were enrolled. 34 patients presented with a focal pattern, whereas 38 patients presented with a diffuse pattern. At multivariate analysis, CRP levels were the only independent predictor of a diffuse ISR pattern [odds ratio, 2.5; 95% confidence interval, 1.4-4.3; p = 0.001)]. Rising CRP tertiles were associated with an increased rate of diffuse pattern (13% versus 26% versus 61%; p for trend = 0.0001)., Conclusion: Baseline CRP serum levels are associated with a diffuse ISR pattern after m-TOR inhibitor DES implantation. These findings suggest that baseline inflammatory reactivity may contribute to aggressive restenosis occurring despite drug elution.
- Published
- 2011
35. Emergence of KPC-producing Klebsiella pneumoniae in Italy.
- Author
-
Fontana C, Favaro M, Sarmati L, Natoli S, Altieri A, Bossa MC, Minelli S, Leonardis F, and Favalli C
- Abstract
Background: The emergence of KPC-producing K. pneumoniae has now become a global concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta lactamases (ESBLs), can accumulate and transfer resistance determinants to other classes of antibiotics. Therefore, infection control guidelines on early identification and control of the spread of organisms carrying these resistant determinants are needed., Findings: Klebsiella pneumoniae carbapenemase (KPC) was detected in two isolates of carbapenem-resistant K. pneumoniae obtained from patients at an Italian teaching hospital. The first strain was isolated from a culture drawn from a central venous device (CVC) in a patient with Crohn's disease who was admitted to a gastroenterology ward. The second was isolated from a urine sample collected from an indwelling urinary catheter in an intensive care unit (ICU) patient with a subdural haematoma. The patients had not travelled abroad. Both isolates were resistant to all beta-lactams and were susceptible to imipenem and meropenem but resistant to ertapenem. Isolates also showed resistance to other classes of non-beta-lactam antibiotics, such as quinolones, aminoglycosides (with the exception for amikacin), trimethoprim-sulfamethoxazole (TMP-SMX) and nitrofurantoin. They were determined to contain the plasmid encoding the carbapenemase gene bla-KPC and were also positive in the Hodge test., Conclusions: This is the second report of KPC-producing isolates in Italy, but the first concerning KPC type 2 gene, and it may have important implications for controlling the transmission of microorganisms resistant to antibiotics.
- Published
- 2010
- Full Text
- View/download PDF
36. A novel culturing system for fluid samples.
- Author
-
Fontana C, Favaro M, Minelli S, Bossa MC, Altieri A, and Favalli C
- Subjects
- Bacteria isolation & purification, Colony Count, Microbial, Humans, Reagent Kits, Diagnostic, Yeasts isolation & purification, Body Fluids microbiology, Microbiological Techniques methods
- Abstract
Background: Large-volume culture methods for sterile body fluids employing automated blood-culture systems increase the recovery of microorganisms compared with traditional plate medium methods. However, in many instances a laboratory receives only small-volume samples., Material/methods: The URO-QUICK system (now HBandL), originally used to process urine samples, was evaluated for organism enrichment and determination of microbial count of fluid samples. Fluid specimens were also evaluated for their residual antimicrobial activity (RAA). The procedures were compared with results from a conventional culture procedure. The 546 samples included 106 endotracheal aspirate, 63 bronchoalveolar lavage, 139 sputum, 47 blood, 105 pleural fluid, 26 cerebrospinal fluids, and 41 peritoneal fluid samples as well as 19 other fluids including synovial fluid (n=5), ascitic fluid (n=9), fluids from the drainage of an infected central venous catheter (n=3), abdominal drainage fluid (n=1), and cholecystic fluid (n=1)., Results: The URO-QUICK system allowed the culture of an additional 44 samples (8%, p=0.007) compared with the traditional culturing method. The RAA test demonstrated good concordance with the reference method, showing specificity and positive predictive value of 100% for each, while the sensitivity and the negative predictive value were 67% and 76%, respectively. The microbial counts evaluated using the URO-QUICK system showed excellent agreement with traditional enumeration methods., Conclusions: The URO-QUICK system may well represent an excellent alternative to solid medium-based recovery and enumeration methods.
- Published
- 2009
37. Performance of strand displacement amplification assay in the detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
- Author
-
Fontana C, Favaro M, Cicchetti O, Minelli S, Pistoia ES, and Favalli C
- Subjects
- Adult, Chlamydia Infections diagnosis, Chlamydia Infections microbiology, DNA, Bacterial genetics, DNA, Ribosomal genetics, Eye microbiology, Female, Gonorrhea diagnosis, Gonorrhea microbiology, Humans, Male, Middle Aged, Nucleic Acid Amplification Techniques statistics & numerical data, RNA, Bacterial genetics, RNA, Ribosomal, 16S genetics, Sensitivity and Specificity, Urogenital System microbiology, Chlamydia trachomatis genetics, Chlamydia trachomatis isolation & purification, Neisseria gonorrhoeae genetics, Neisseria gonorrhoeae isolation & purification, Nucleic Acid Amplification Techniques methods
- Abstract
This study is a critical analysis of certain amplification assays for detecting Chlamydia trachomatis and Neisseria gonorrhoeae infections which have demonstrated that the plasmid-free variant of C. trachomatis is frequently responsible for infection in our patients. Specifically, we evaluated the performance of the strand displacement amplification (SDA) assay in detecting either C. trachomatis or N. gonorrhoeae in 1,190 clinical samples, both urogenital and ocular, from 1,005 consecutive patients. The results obtained with the BDProbeTec ET System were compared with three referenced amplification methods for C. trachomatis (detecting the 16S rRNA gene, the omp1 gene and the plasmid of C. trachomatis) and with both the culture method as well as an amplification assay followed by genetic identification performed using the MicroSeq 500 16S ribosomal DNA-based system for N. gonorrhoeae. The sensitivity of SDA (76%) in detecting C. trachomatis is significantly low when compared with that of other molecular techniques employing 16S rDNA or omp1 as a target. The specificity of the methods for detecting C. trachomatis was excellent, ranging from 99.4 to 100%. Furthermore, the results of SDA in detecting N. gonorrhoeae also provided excellent results (100% specificity and sensitivity).
- Published
- 2005
38. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates.
- Author
-
Fontana C, Favaro M, Minelli S, Criscuolo AA, Pietroiusti A, Galante A, and Favalli C
- Subjects
- Base Sequence, Helicobacter pylori drug effects, Helicobacter pylori isolation & purification, Humans, Point Mutation, Polymerase Chain Reaction, RNA, Ribosomal, 23S drug effects, Clarithromycin pharmacology, Drug Resistance, Bacterial genetics, Helicobacter pylori genetics, RNA, Ribosomal, 23S genetics
- Abstract
Resistance of Helicobacter pylori to clarithromycin occurs with a prevalence ranging from 0 to 15%. This has an important clinical impact on dual and triple therapies, in which clarithromycin seems to be the better choice to achieve H. pylori eradication. In order to evaluate the possibility of new mechanisms of clarithromycin resistance, a PCR assay that amplified a portion of 23S rRNA from H. pylori isolates was used. Gastric tissue biopsy specimens from 230 consecutive patients were cultured for H. pylori isolation. Eighty-six gastric biopsy specimens yielded H. pylori-positive results, and among these 12 isolates were clarithromycin resistant. The latter were studied to detect mutations in the 23S rRNA gene. Sequence analysis of the 1,143-bp PCR product (portion of the 23S rRNA gene) did not reveal mutation such as that described at position 2142 to 2143. On the contrary, our findings show, for seven isolates, a T-to-C transition at position 2717. This mutation conferred a low level of resistance, equivalent to the MIC for the isolates, selected using the E-test as well as using the agar dilution method: 1 micro g/ml. Moreover, T2717C transition is located in a highly conserved region of the 23S RNA associated with functional sites: domain VI. This fact has a strong effect on the secondary structure of the 23S RNA and on its interaction with macrolide. Mutation at position 2717 also generated an HhaI restriction site; therefore, restriction analysis of the PCR product also permits a rapid detection of resistant isolates.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.